Fool.com
The World's Greatest Investing Community
Results 51 - 60 of 425 : Previous 2 3 4 5 6 7 8 9 10 Next
Merck and Schering: A Less Ugly Bride and Groom
Sometimes "better than expected" is still bad.
An FDA advisory committee smacked down its drug candidate.
Less Inflammation From Abbott's Quarter
Humira is headed back in the right direction.
Take it.
One name worth buying today.
Check out these solid stocks that pay you to hold them.
Is the News Good or Bad? Who Cares! Sell!
Don't sell the rumors.
I will gladly pay you Tuesday ...
Yes! It Can Handle the Pressure
Rigel does it quite well, in fact.
At Last, a Heartening Drug Approval
French drug giant sanofi-aventis gets FDA approval for a drug to treat an erratic heartbeat.
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK